August 15, 2013 – FDA Drug Safety Communication issued over increased risk of permanent nerve damage / peripheral neuropathy with fluoroquinolone antibiotics.
August 15, 2013 – FDA Drug Safety Communication issued over increased risk of permanent nerve damage / peripheral neuropathy with fluoroquinolone antibiotics.